References
- Talanian, R. V.; Brady, K. D.; Cryns, V. L. J. Med. Chem. 2000, 43, 3351 https://doi.org/10.1021/jm000060f
- Thornberry, N. A.; Lazebrik, Y. Science 1998, 281, 1312 https://doi.org/10.1126/science.281.5381.1312
- Earnshaw, W. C. Annu. Rev. Biochem. 1999, 68, 383 https://doi.org/10.1146/annurev.biochem.68.1.383
- Porter, A. G.; Janicke, R. U. Cell Death Differ. 1999, 6, 99 https://doi.org/10.1038/sj.cdd.4400476
- Nicholson, D. W.; Thornberry, N. A. Trends Biochem. Sci. 1997, 22, 299 https://doi.org/10.1016/S0968-0004(97)01085-2
- Estiarte, M. A.; Rich, D. H. Burger's Medicinal Chemistry and Drug Design, 6th ed.; 2003; Vol. 1, p 633
- Lee, D.; Long, S. A.; Murray, J. H.; Adams, J. L.; Nuttall, M. E.; Nadeau, D. P.; Kikly, K.; Winkler, J. D.; Sung, C.-M.; Ryan, M. D.; Levy, M. A.; Keller, P. M.; DeWolf, W. E. Jr. J. Med. Chem. 2001, 44, 2015 https://doi.org/10.1021/jm0100537
- Hyun, K. H.; Kwack, I. Y.; Lee, D. Y.; Park, H. Y.; Lee, B.-S.; Kim, C.-K. Bull. Korean Chem. Soc. 2004, 25, 1801 https://doi.org/10.5012/bkcs.2004.25.12.1801
- San Juan, A. A.; Cho, S. J. Bull. Korean Chem. Soc. 2005, 26, 952 https://doi.org/10.5012/bkcs.2005.26.6.952
- SYBYL Molecular Modeling Software; Tripos Inc.: St. Louis, MO 63144, U.S.A
- Lee, D.; Chan, G.; Vaidya, K. S.; Francis, T. A.; Nadeau, D. P.; Lark, M. W.; Gowen, M.; Kikly, K.; Winkler, J. D.; Sung, C.-M.; Long, S. A.; Adams, J. L.; Debouck, C.; Richardson, S.; Levy, M. A.; Dewolf, W. E., Jr.; Keller, P. M.; Tomaszek, T.; Head, M. S.; Ryan, M. D.; Haltiwanger, R. C.; Liang, P.-H.; Janson, C. A.; Mcdevi, P. J. J. Biol. Chem. 2000, 275, 16007 https://doi.org/10.1074/jbc.275.21.16007
- Hansch, C.; Leo, A. In Exploring QSAR; American Chemical Society: Washington DC, 1995
- Cramer, R. D.; Patterson, D. E.; Bunce, J. D. J. Am. Chem. Soc. 1988, 110, 5959 https://doi.org/10.1021/ja00226a005
- Dean, P. M. In Molecular Simularity in Drug Design; Blackie Academic & Professional: Glasgow, 1995; p 291
- Klebe, G.; Abraham, U.; Mietzner, T. J. Med. Chem. 1994, 37, 4130 https://doi.org/10.1021/jm00050a010
Cited by
- Structure-activity correlation for a series of isatin derivatives, inhibitors of caspase 3 vol.79, pp.3, 2009, https://doi.org/10.1134/S1070363209030244
- Prediction of the Antagonistic Activity of Aryl Benzyl Ethers against LTD4 by Using 3D-CoMFA Model Developed with Pranlukast Analogues vol.27, pp.7, 2006, https://doi.org/10.5012/bkcs.2006.27.7.1025
- Docking Studies on Formylchromone Derivatives as Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors vol.28, pp.7, 2006, https://doi.org/10.5012/bkcs.2007.28.7.1141
- Synthesis of bilayer oleic acid-coated Fe3O4 nanoparticles and their application in pH-responsive Pickering emulsions vol.310, pp.1, 2006, https://doi.org/10.1016/j.jcis.2007.01.081
- QM and Pharmacophore based 3D-QSAR of MK886 Analogues against mPGES-1 vol.29, pp.3, 2008, https://doi.org/10.5012/bkcs.2008.29.3.647
- 3D Quantitative and Qualitative Structure-Activity Relationships of the δ -Opioid Receptor Antagonists vol.29, pp.3, 2006, https://doi.org/10.5012/bkcs.2008.29.3.656
- Docking and Virtual Screening Studies for New Leads of Boar Salivary Lipocalin vol.29, pp.5, 2006, https://doi.org/10.5012/bkcs.2008.29.5.959
- Isatin sulfonamides: potent caspases-3 and -7 inhibitors, and promising PET and SPECT radiotracers for apoptosis imaging vol.7, pp.9, 2006, https://doi.org/10.4155/fmc.15.52